ReviewBMJ open gastroenterology2026

Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era.

Shuanggang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.